Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma-Reference-Cited by-同舟云学术

Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma

Published:2017-03 Issue:2 Volume:16 Page:198-206
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Guarino Maria,Picardi Marco,Vitiello Anna,Pugliese Novella,Rea Matilde,Cossiga Valentina,Pane Fabrizio,Caporaso Nicola,Morisco Filomena

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Link

https://publisherspanel.com/icid/pdf/1231579

Reference62 articles.

1. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J Viral Hepatitis,2004

2. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity;Ott;Vaccine,2012

3. A 2010 update on occult hepatitis B infection;Raimondo;Pathol Biol (Paris),2010

4. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between sero-logical patterns and occult infection;Romanò;Blood Transfus,2013

5. Statements from the Taormina expert meeting on occult hepatitis B virus infection;Raimondo;J Hepatol,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis;Seminars in Oncology;2024-08

2. The role of treatment of hepatitis C with direct‐acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta‐analysis;Journal of Viral Hepatitis;2024-07-24

3. Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation;Alimentary Pharmacology & Therapeutics;2022-11-21

4. HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus;BMC Endocrine Disorders;2022-11-12

5. Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals;Journal of Clinical Medicine;2022-09-29